Firethorn Wealth Partners LLC acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 13,227 shares of the conglomerate’s stock, valued at approximately $2,930,000. Danaher makes up about 0.9% of Firethorn Wealth Partners LLC’s holdings, making the stock its 26th biggest position.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Danaher during the second quarter worth $10,492,520,000. Jupiter Topco LLC acquired a new position in shares of Danaher in the second quarter valued at about $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher in the second quarter valued at about $1,287,949,000. Bank of America Corp DE bought a new position in Danaher during the second quarter worth about $993,846,000. Finally, Legal & General Group Plc bought a new position in Danaher during the second quarter worth about $801,056,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Trending Headlines about Danaher
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: Danaher and NVIDIA announced a collaboration combining Danaher’s scientific instruments, laboratory workflows, automation technologies and data with NVIDIA’s accelerated computing and AI capabilities. The companies aim to advance autonomous science and speed up research, potentially creating new growth opportunities in life-science tools. Danaher Collaborates with NVIDIA to Advance Autonomous Science
- Positive Sentiment: Danaher is reportedly preparing to launch its first AI-powered autonomous laboratory, expected to operate at commercial scale in early 2027. The initiative could support demand for Danaher’s instruments, software and laboratory automation offerings as AI adoption expands. How to Invest in AI Drug Discovery
- Positive Sentiment: Zacks said Danaher has two indicators associated with a potential earnings beat ahead of its upcoming report. A stronger-than-expected result could reinforce investor confidence following the company’s previous quarterly beat on revenue and earnings. Danaher Earnings Expected to Grow
- Positive Sentiment: Morgan Stanley maintained its $240 price target for DHR, signaling continued confidence in the stock’s outlook and leaving room for further appreciation based on the referenced trading level. Morgan Stanley Keeps $240 Target for Danaher
- Neutral Sentiment: Danaher appointed Daniel L. Comas and Robert Hershberg to its board, expanding it to 13 members. The appointments may strengthen governance and industry expertise but are unlikely to materially affect near-term trading. Danaher Announces Board Appointments
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Danaher
Danaher Price Performance
DHR traded up $1.26 during trading on Wednesday, hitting $224.10. 1,890,805 shares of the stock traded hands, compared to its average volume of 4,448,106. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $157.54 billion, a price-to-earnings ratio of 39.79, a PEG ratio of 2.78 and a beta of 0.76. The business has a 50 day moving average price of $212.41 and a 200 day moving average price of $195.13.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Read More
- Five stocks we like better than Danaher
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
- How a Hurricane Could Help Some Refineries—and Hurt Others
- Intel Bets on Cheaper AI as Foundry Losses Mount
- Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
